A review of the Vaccine Adverse Event Reporting System database

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.3, 2004-03, pp. : 691-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

Data Mining in the US using the Vaccine Adverse Event Reporting System

By Iskander John

Drug Safety, Vol. 29, Iss. 5, 2006-01 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database

By Motola Domenico

Drug Safety, Vol. 35, Iss. 4, 2012-04 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)

By Emily Jane Woo Ball Robert Burwen Dale R. Braun M. Miles

Drug Safety, Vol. 31, Iss. 8, 2008-01 ,pp. : 667-674

Adis International

Access to resources Recommend Favorite